{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:32Z","timestamp":1786998332843,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ymgme.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T18:38:35Z","timestamp":1633459115000},"page":"274-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigation of a dysmorphic facial phenotype in patients with Gaucher disease types 2 and 3"],"prefix":"10.1016","volume":"134","author":[{"given":"Emily","family":"Daykin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magy","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Hassib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emory","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.09.008_bb0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-genom-083118-015345","article-title":"New diagnostic approaches for undiagnosed rare genetic diseases","volume":"21","author":"Hartley","year":"2020","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41436-020-00975-0","article-title":"(Un)standardized testing: the diagnostic odyssey of children with rare genetic disorders in Alberta, Canada","volume":"23","author":"Michaels-Igbokwe","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajhg.2021.01.003","article-title":"The diagnostic odyssey: our family's story","volume":"108","author":"Miller","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-021-01706-7","article-title":"Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups","volume":"16","author":"Rintell","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12687-017-0320-x","article-title":"Diagnosis of rare diseases under focus: impacts for Canadian patients J.","volume":"9","author":"Esquivel-Sada","year":"2018","journal-title":"Commun. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1586\/erm.11.70","article-title":"Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing","volume":"11","author":"Kingsmore","year":"2011","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.008_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12687-021-00520-9","article-title":"Rare disease care pathways in the EU: from odysseys and labyrinths towards highways","volume":"12","author":"Tumiene","year":"2021","journal-title":"J. Commun. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0268-960X(88)90009-4","article-title":"Gaucher disease","volume":"2","author":"Beutler","year":"1988","journal-title":"Blood Rev"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0045","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease - Gaucher Disease","author":"Grabowski","year":"2014"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","article-title":"Gaucher disease: Progress and ongoing challenges","volume":"120","author":"Mistry","year":"2017","journal-title":"Molecular genetics and metabolism"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2021.06.009","article-title":"Throwing a spotlight on under-recognized manifestations of Gaucher disease: Pulmonary involvement, lymphadenopathy and Gaucheroma","volume":"133","author":"Ramaswami","year":"2021","journal-title":"Molecular genetics and metabolism"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2020.12.291","article-title":"Gaucher disease: Basic and translational science needs for more complete therapy and management","volume":"132","author":"Grabowski","year":"2021","journal-title":"Molecular genetics and metabolism"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0065","first-page":"72","article-title":"Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history","volume":"12","author":"Baris","year":"2014","journal-title":"Pediatric endocrinology reviews\u202f:"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0070","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1212\/NXG.0000000000000055","article-title":"Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in Egypt","volume":"2","author":"Abdelwahab","year":"2016","journal-title":"Neurol Genet"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2021.01.002","article-title":"Diagnosing neuronopathic Gaucher disease: new considerations and challenges in assigning Gaucher phenotypes","volume":"132","author":"Daykin","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ymgme.2019.06.002","article-title":"Five-parameter evaluation of dysphagia: A novel prognostic scale for assessing neurological decline in Gaucher disease type 2","volume":"127","author":"Seehra","year":"2019","journal-title":"Molecular genetics and metabolism"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0085","doi-asserted-by":"crossref","unstructured":"T. Roshan Lal G.K. Seehra A.M. Steward C.N. Poffenberger E. Ryan N. Tayebi G. Lopez E. Sidransky, The natural history of type 2 Gaucher disease in the 21st century: a retrospective study Neurology 95 (2020) e2119\u2013e2130.","DOI":"10.1212\/WNL.0000000000010605"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0090","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jimd.12235","article-title":"The definition of neuronopathic Gaucher disease","volume":"43","author":"Schiffmann","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0095","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","article-title":"The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis","volume":"160","author":"Kaplan","year":"2006","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0110","doi-asserted-by":"crossref","first-page":"F225","DOI":"10.1136\/adc.2006.110619","article-title":"Dysmorphology demystified","volume":"92","author":"Reardon","year":"2007","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1542\/pir.2018-0331","article-title":"Dysmorphology","volume":"40","author":"Kim","year":"2019","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clp.2019.10.009","article-title":"Dysmorphology in a Genomic Era","volume":"47","author":"Basel","year":"2020","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41591-018-0279-0","article-title":"Identifying facial phenotypes of genetic disorders using deep learning","volume":"25","author":"Gurovich","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s10038-019-0619-z","article-title":"Evaluation of Face2Gene using facial images of patients with congenital dysmorphic syndromes recruited in Japan","volume":"64","author":"Mishima","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0135","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ajmg.a.61720","article-title":"Differentiating molecular etiologies of Angelman syndrome through facial phenotyping using deep learning","volume":"182","author":"Gomez","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2021.09.008_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cge.13588","article-title":"Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients","volume":"96","author":"Li","year":"2019","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0145","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s10038-019-0673-6","article-title":"Using facial analysis technology in a typical genetic clinic: experience from 30 individuals from a single institution","volume":"64","author":"Zarate","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10545-018-0174-3","article-title":"Advances in computer-assisted syndrome recognition by the example of inborn errors of metabolism","volume":"41","author":"Pantel","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0155","first-page":"1","article-title":"Current and emerging pharmacotherapy for Gaucher disease in pediatric populations","author":"Sam","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ymgme.2021.09.008_bb0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of Type 2 Gaucher disease","volume":"114","author":"Weiss","year":"2015","journal-title":"Molecular genetics and metabolism"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:50:20Z","timestamp":1761090620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1096719221007848"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.09.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of a dysmorphic facial phenotype in patients with Gaucher disease types 2 and 3","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}